Literature DB >> 1295765

Value of measurement of C-reactive protein in febrile patients with hematological malignancies.

E Rintala1, K Irjala, J Nikoskelainen.   

Abstract

The maximum serum levels of C-reactive protein (CRP) in 126 patients with hematological malignancies who had 554 febrile episodes were analyzed retrospectively with regard to documented infections and fever of unknown origin. The CRP levels were significantly higher when the blood culture was positive than when it was negative (p = 0.002). The CRP levels were significantly higher when the infection focus was identified than when it was not (p = 0.010). In patients with fever of unknown origin the CRP was significantly lower than in patients with microbiologically documented infections (p < 0.001). Cytotoxic treatment neither reduced nor enhanced the CRP reaction. The serial measurement of CRP is a reliable and readily available means for differentiating between bacterial infections and other causes of fever in patients with hematological malignancies, also during neutropenia and after cytotoxic treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295765     DOI: 10.1007/bf01967785

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  The effects of methotrexate on the production and activity of interleukin-1.

Authors:  R Segal; E Mozes; M Yaron; B Tartakovsky
Journal:  Arthritis Rheum       Date:  1989-04

2.  C-reactive protein in the management of children with fever after allogeneic bone marrow transplantation.

Authors:  C de Bel; E Gerritsen; G de Maaker; A Moolenaar; J Vossen
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

3.  IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo.

Authors:  S Marinkovic; G P Jahreis; G G Wong; H Baumann
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

4.  C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients.

Authors:  P C Ligtenberg; I M Hoepelman; G A Oude Sogtoen; A W Dekker; I van der Tweel; M Rozenberg-Arska; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

Review 5.  Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer.

Authors:  C Toniatti; R Arcone; B Majello; U Ganter; G Arpaia; G Ciliberto
Journal:  Mol Biol Med       Date:  1990-06

Review 6.  Fever and infection in leukemic patients: a study of 494 consecutive patients.

Authors:  G P Bodey; V Rodriguez; H Y Chang
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

7.  C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia.

Authors:  K P Schofield; F Voulgari; D I Gozzard; M J Leyland; N J Beeching; J Stuart
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

8.  Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate.

Authors:  K M Connolly; V J Stecher; E Danis; D J Pruden; T LaBrie
Journal:  Int J Immunopharmacol       Date:  1988

Review 9.  Evaluation of fever in the patient with cancer.

Authors:  P A Pizzo
Journal:  Eur J Cancer Clin Oncol       Date:  1989

Review 10.  Molecular basis of fever in humans.

Authors:  C A Dinarello; S M Wolff
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

View more
  9 in total

1.  Tumor-associated Fever in Recurrent Breast Cancer with Liver Metastases.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

2.  Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.

Authors:  Yasuhiro Ebihara; Kiyoko Kobayashi; Akaru Ishida; Tomoya Maeda; Naoki Takahashi; Yoshitada Taji; Norio Asou; Kenji Ikebuchi
Journal:  J Clin Lab Anal       Date:  2017-01-30       Impact factor: 2.352

3.  The effects of pretransplant conditioning, graft-versus-host disease and sepsis on the CRP levels in bone marrow transplantation.

Authors:  E Rintala; K Remes; T T Salmi; P Koskinen; J Nikoskelainen
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

4.  Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.

Authors:  C Cheval; J F Timsit; M Garrouste-Orgeas; M Assicot; B De Jonghe; B Misset; C Bohuon; J Carlet
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

5.  Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.

Authors:  Ahmad Baraka; Marwa Zakaria
Journal:  Int J Hematol       Date:  2018-04-03       Impact factor: 2.490

6.  TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values.

Authors:  J L Herrmann; H Blanchard; P Brunengo; P H Lagrange
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

7.  Incidence and management of infections in patients with acute leukemia following chemotherapy in general wards.

Authors:  Sasmita Biswal; Chaitali Godnaik
Journal:  Ecancermedicalscience       Date:  2013-04-22

8.  C-Reactive Protein Monitoring Predicts Neutropenic Fever Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Authors:  Vidya Kollu; Sarah L Mott; Rafiullah Khan; Umar Farooq; Yogesh Jethava; Ince Dilek; Guido Tricot
Journal:  Cureus       Date:  2018-07-08

9.  Characteristics of febrile patients with normal white blood cell counts and high C-reactive protein levels in an emergency department.

Authors:  Kuan-Ting Liu; Tzeng-Jih Lin; Hon-Man Chan
Journal:  Kaohsiung J Med Sci       Date:  2008-05       Impact factor: 2.744

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.